These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1755008)

  • 21. [Effects of nitric oxide on platelet function in burned rats].
    Peng X; Feng J; Wang S
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Nov; 15(6):428-30. PubMed ID: 11501077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interaction between thrombocytes and the coronary system in the presence of SIN 1 and nitroglycerin after endothelial damage].
    Rösen R; Bernards W; Jumpertz K; Kreie KJ; Wiesmüller G; Klaus W
    Z Kardiol; 1991; 80 Suppl 5():23-7. PubMed ID: 1776331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of platelet aggregation by endothelium-derived relaxing factor-like agents].
    Gerzer R; Karrenbrock B; Drummer C; Heim JM
    Med Klin (Munich); 1990 Feb; 85 Suppl 1():18-22. PubMed ID: 2185403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty.
    Groves PH; Penny WJ; Cheadle HA; Lewis MJ
    Cardiovasc Res; 1992 Jun; 26(6):615-9. PubMed ID: 1451141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-ischemic actions of molsidomine by venous and large coronary dilatation in combination with antiplatelet effects.
    Bassenge E; Mülsch A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S23-8. PubMed ID: 2484695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of SIN-1 on the early phases of blood platelet activation].
    Weill D; Maclouf J; Rendu F; Levy-Toledano S
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):212. PubMed ID: 3550637
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of exogenous nitric oxide and superoxide on interleukin-8 from human polymorphonuclear leucocytes.
    Cuthbertson BH; Galley HF; Webster NR
    Br J Anaesth; 1997 Jun; 78(6):714-7. PubMed ID: 9215025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
    Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
    Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions.
    Jung F; Mrowietz C; Seyfert UT; Grewe R; Franke RP
    Clin Hemorheol Microcirc; 2003; 28(4):189-99. PubMed ID: 12897410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B; Grewe R; Loeschke K; Gerzer R
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R; Haslam RJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light and scanning-electron microscopic examination of coronary stents in a perfusion-model. Effects of an NO-donor/quantitative analysis.
    Franke RP; Reuter P; Mrowietz C; Bach R; Jung F
    Clin Hemorheol Microcirc; 2001; 24(2):101-9. PubMed ID: 11381185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
    Kalinowski L; Matys T; Chabielska E; Buczko W; Malinski T
    Hypertension; 2002 Oct; 40(4):521-7. PubMed ID: 12364357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of molsidomine on platelet activation in coronary ischemia].
    Wautier JL
    Presse Med; 1988 May; 17(20):1037-40. PubMed ID: 2969100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-ischemic effects of SIN-1, a molsidomine metabolite, during coronary angioplasty and antiplatelet effects in humans].
    Darius H; Erbel E; Schmucker B; Reusch U; Meyer J
    Presse Med; 1988 May; 17(20):1033-6. PubMed ID: 2969099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
    Gerzer R; Karrenbrock B; Siess W; Heim JM
    Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of SIN-1 on the activation of phospholipase C and calcium mobilization induced by thrombin in blood platelets].
    Simon MF; Chap H; Douste-Blazy L
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):213-4. PubMed ID: 3550638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.